This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: BIIB CLMT GPOR ORIG


athenahealth was initiated with a neutral rating at Sterne Agee. $84 price target. Valuation is fair, Sterne Agee said.

Audience (ADNC) was initiated with a hold rating at TheStreet Ratings.

Biogen Idec (BIIB - Get Report) was downgraded at Citigroup to neutral from buy. Price target is $236. There is risk that regulatory data protection for the company's flagship MS drug, Tecfidera, is limiting valuation, Citi said.

Bob Evans Farms (NOK) was initiated with an overweight rating and $57 price target at Oppenheimer. Both the restaurant and grocery businesses are emerging from transformational initiatives, improving performance, Oppenheimer said.

Calumet Specialty Products (CLMT - Get Report) was initiated with an outperform rating and $40 price target at Credit Suisse. Geographical and product diversity should provide solid distribution growth, Credit Suisse said.

Gulfport Energy (GPOR - Get Report) coverage was reinstated at Credit Suisse with an outperform rating and $72 price target. Additional Utica inventory and a quicker than anticipated ramp to a seven-rig program will drive upside, Credit Suisse said.

Allscripts Healthcare Solutions (MDRX) was initiated with a buy rating at Sterne Agee. $17 price target. In the third inning of a long-term turnaround, Sterne Agee said.

Lakes Entertainment (LACO) was downgraded to hold at TheStreet Ratings.

Ocean Rig (ORIG - Get Report) was downgraded at Credit Suisse to neutral from outperform. Upside is limited given the stock's recent run, even as management returns cash to shareholders, Credit Suisse said. Price target is $19.

PAREXEL (PRXL) was initiated with a neutral rating at Sterne Agee. $44 price target. Successfully climbed PIII CRO market share ladder, Sterne Agee said.

Boston Beer (SAM) was upgraded at Goldman Sachs to neutral from sell. $162 target price. Near-term volume upside potential, Goldman said.

Texas Roadhouse (TXRH) was initiated with a buy rating at Bank of America/Merrill Lynch. $28 price target. Well-established brand with attractive valuation, BofA/Merrill said.


Aegerion Pharmaceuticals (AEGR) price target was raised to $88 at J.P. Morgan. Encouraging physician feedback and the recent approval recommendation for Lojuxta have improved the valuation outlook, J.P. Morgan said.

Airgas (ARG) estimates were reduced at Jefferies. Slow start to the year and weak construction demand, said Jefferies.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BIIB $273.77 0.03%
CLMT $4.09 -4.90%
GPOR $27.91 -7.00%
ORIG $1.86 -4.60%
AAPL $95.18 1.60%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs